Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial | Zendy

Mansi Kanhere | Zendy; Jiabei He | Zendy; Benoît Chassaing | Zendy; Thomas R. Ziegler | Zendy; Jessica A. Alvarez | Zendy; E. Ivie | Zendy; Hao Li | Zendy; John Hanfelt | Zendy; Andrew T. Gewirtz | Zendy; Vin Tangpricha | Zendy

Open Access

Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Author(s) -

Mansi Kanhere,

Jiabei He,

Benoît Chassaing,

Thomas R. Ziegler,

Jessica A. Alvarez,

E. Ivie,

Hao Li,

John Hanfelt,

Andrew T. Gewirtz,

Vin Tangpricha

Publication year - 2017

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2017-01983

Subject(s) - vitamin d and neurology , cystic fibrosis , placebo , vitamin , medicine , gut flora , gastroenterology , vitamin d deficiency , physiology , microbiome , roseburia , biology , immunology , bioinformatics , pathology , lactobacillus , alternative medicine , genetics , bacteria

Disruption of gut microbiota may exacerbate severity of cystic fibrosis (CF). Vitamin D deficiency is a common comorbidity in patients with CF that may influence composition of the gut microbiota.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research